Sabitlenmiş Tweet
Put simply, people like new narratives, and peptides is the hottest narrative in the world right now thanks to glucagon-like peptide-1 receptor agonists [GLP-1s]. GLP1s have effectively de-risked the entire category, and JFK Jr loosening the regs this summer will go some way to further de-risk. Alongside this, AI is rapidly increasing peptide development. One project using agents right now for peptide discovery + actual connections to wetlabs [step prior to clinical trials] is $FOLD, a recent BIO Hackathon winner.
What most people miss is that peptides already have demand, it just isn’t structured. Biohackers, clinics and longevity communities are actively experimenting in real time, but outcomes are fragmented, anecdotal and mostly lost. There’s no system capturing what works, feeding it back into discovery and improving over time. Demand for this exists but data is limited. This is the gap that @clarity_proto fill.
Traditional biotech doesn’t really solve this either. It’s slow, capital intensive and optimised for billion dollar drugs, whereas peptides often sit in an awkward middle ground, too early, too niche or not patentable enough to attract serious funding. As a result, a lot of potential discovery simply never compounds because no one is capturing the learnings in a continuous loop.
Clarity is going after that gap, starting with neurologics. Focusing on neurodegenerative diseases like dementia gives them a high signal entry point, where protein misfolding and peptide interaction are well understood and measurable. Neurologics is just the starting point, this same system will soon be applied to all and any peptides from longevity, performance, metabolic health and beyond. Clarity will be the infra for a much broader peptide discovery system.
The model is simple:
1. AI discovers peptides
2. Best candidates get surfaced -> wetlabs/trials
3. Products get distributed for real-world use
4. Usage generates data
5. Data feeds back into the model
Basically, how you go from "biohacking products" to a compounding discovery engine through the fusion of GPUs x AI agents x protein folding x wetlabs.
cryptoceo@cryptoceo_
Peptides is the narrative of 2026 Significant capital already sits in bio protocol, but a 24/7 automated peptide pipeline exists at ~300k fdv > agents running 24/7 > peptides designed + scored > real outputs already live > product layer + distribution planned > provisional ip protections underway > recent hackathon winner Tldr: a live, ai-driven peptide research platform Or simply: github for peptides Hard to see this staying here if it executes
English
